EXCITE International News

The latest news, announcements and press releases from EXCITE.


FEATURED

EXCITE International Becomes a Member of the FDA's Early Payor Feedback Program

November 23, 2022

It is a great pleasure to announce that EXCITE International has become a member of the FDA's Early Payor Feedback Program (EPFP) set up by the Center for Devices and Radiological Health (CDRH). 

Learn More here

EXCITE International Early Technology Review: Unprecedented Opportunity to Engage with the Largest U.S. Payers and Renowned Experts


October 7, 2022

Technologies that improve patient outcomes and deliver service efficiencies deserve to be well-integrated into healthcare systems. Unfortunately, the path to adoption is complex, and many companies get bogged down due to a poor understanding of what payers and health professionals require.

In response, the not-for-profit EXCITE International has developed a collaborative process for Early Technology Review (ETR) that includes direct engagement with large payers and accomplished clinical experts. 

Learn More here


EXCITE International has become a member of FDA’s Early Payor Feedback Program

Posted Nov 23rd, 2022

It is a great pleasure to announce that EXCITE International has become a member of the FDA’s Early Payor Feedback Program (EPFP) set up by the Center for Devices and Radiological Health (CDRH). This is a voluntary opportunity for medical device sponsors to obtain payor input on clinical trial design or other plans for gathering clinical evidence needed to support positive coverage decisions.

Read more

EXCITE International & Izotropic Corporation Announce Partnership

Posted Apr 6th, 2021

With this EXCITE partnership, Izotropic will engage with EXCITE’s global network to align the device, clinical trial design, and regulatory strategy with potential payor groups, methodologists, and expert end-users. 

Read more

Leaders in Bringing Innovative Ideas to Healthcare

Posted Jun 28th, 2022

EXCITE International is a not for profit collaborative focused on fixing unacceptable market adoption problems for innovative nondrug medical technologies.

Read more

2020 Summit Plans Are Underway

Posted Jan 9th, 2020

We are pleased to announce that plans for the annual EXCITE International Summit are underway. A more formal separate announcement will be made as soon as the Planning and Program Committees have been struck and the venue confirmed. ...

Read more

New Executive Board Member

Posted Jan 8th, 2020

EXCITE International is pleased to announce the appointment of Dr. Jeff Popma to its Board. Jeff is Chair of EXCITE International’s Scientifi...

Read more

New Chair for EXCITE International Payers' Advisory Committee

Posted Aug 26th, 2019

EXCITE International wishes to announce that Naomi Aronson will be stepping down as Chair of the Payers’ Advisory Committee (PAC) effective August 31st. We are, at the same time pleased to announce that Jo Carol Hiatt, Chair of the Inter-Regional New Technology Committee at Kaiser Permanente has agreed to succeed Naomi as Chair.

Read more

Payers' Advisory Committee Membership Grows by Two

Posted Aug 22nd, 2019

EXCITE International's Payers' Advisory Committee welcomes two new members. Robert Garnett is President, Amerigroup Tennessee, part of the Medicaid Central Region and Government Business Division at Anthem, Inc. where he is responsible for the strategic, fiscal, regulatory, and operational leadership of the health plan. Stig A. Slørdahl MD, is CEO of The Central Norway Regional Health Authority. He was dean of the Faculty of Medicine at the Norwegian University of Science and Technology (NTN...

Read more

New Scientific Collaboration Chair Appointed

Posted Jun 11th, 2019

EXCITE International is pleased to announce the appointment of Jeffrey J. Popma, MD as chair of its Scientific Collaboration. This appointment follows the retirement of Dr Bryan Luce who has been chair since the inception of EXCITE International in 2016.

Read more

EXCITE International Health Technology Global Summit - Proceedings

Posted Apr 1st, 2019

EXCITE International held a Health Technology Global Summit in Washington, DC in March 2019. The event was well attended and very well received. To learn more about the Summit, Read more

EXCITE International Update June 2018

Posted Jun 26th, 2018

EXCITE International is pleased to share with you recent news highlighting the ongoing expansion and partnership development taking place in our organization. Get acquainted with our new executive board members, Sir Bruce Keogh and Carl Christian Gilhuus-Moe in addition to latest developments in our offerings, invaluable partnerships, the launch of new board committees and recent meetings and presentations.

Read more

EXCITE International Model Sparks Immediate Interest in the Silicon Valley

Posted Oct 20th, 2016

EXCITE International’s approach to accelerating health technology innovation generated immediate interest at the 9th Annual Medical Technology Executive Forum hosted by the Medical Device Manufacturers Association (MDMA) in Palo Alto, California on September 29, 2016.

Read more

EXCITE International Convenes Key Leaders in Inaugural Summit

Posted Aug 3rd, 2016

EXCITE International (Excellence in Clinical Innovation & Technology Evaluation) convened high-level health care leaders from around the world at an inaugural multijurisdictional Summit on June 2-3, 2016 in Toronto.

Read more

EXCITE International Establishes Executive Board, Names Officers

Posted May 2nd, 2016

The inaugural meeting of the Executive Board for EXCITE International occurred in Toronto on Feb 23, 2016.

Read more

EXCITE International Incorporated in October 2015

Posted Mar 1st, 2016

Incorporated in March 2016, EXCITE International represents a major positive disruption in the application of evidence to the evaluation of technology and has the potential to be a first-of-its kind global engine for medical technology innovation.

Read more

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.